1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on June 24,2025 Registration Statement No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 BONE BIOLOGICS CORPORATION(Exact name of registra

2、nt as specified in its charter)Delaware 2834 42-1743430(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)2 Burlington Woods Drive,Suite 100Burlington,MA 01803(781)552-4452(Address,including zip cod

3、e,and telephone number,including area code,of registrants principal executive offices)Jeffrey FrelickChief Executive OfficerBone Biologics Corporation2 Burlington Woods Drive,Suite 100Burlington,MA 01803(781)552-4452(Name,address,including zip code,and telephone number,including area code,of agent f

4、or service)Copies to:Alexander R.McClean,Esq.Harter Secrest&Emery LLP1600 Bausch&Lomb PlaceRochester,New York 14604(585)232-6500 Steven M.Skolnick,Esq.Lowenstein Sandler LLP1251 Avenue of the AmericasNew York,New York 10020(212)262-6700 Approximate date of commencement of proposed sale to the public

5、:As soon as practicable after the effective date of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933 check the following box:If this Form is filed to register add

6、itional securities for an offering pursuant to Rule 462(b)under the Securities Act,please checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective amendment filed pursuant to